Evidence map›Paper›PMID 40331602›Full record

ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2026

Current practice of biologic augmentation techniques to enhance the healing of meniscal repairs: A collaborative survey within the Meniscus International Network (MenIN) Study Group.

James Robinson, Iain R Murray, Gilbert Moatshe, Jorge Chahla, Luke V Tollefson, David A Parker, Filippo Familiari, Robert F LaPrade, Nicholas N DePhillipo, Meniscus International Network (MenIN) Study Group

Abstract read
In one paragraph

Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Risk Factors for Failure of Meniscal Repair.Current reviews in musculoskeletal medicine · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

James RobinsonKnee Specialists, Bristol, UK.
Iain R MurrayEdinburgh Orthopaedics, University of Edinburgh, Edinburgh, UK.
Gilbert MoatsheOslo Sport Trauma Research Center, Norwegian School of Sports Science, Oslo, Norway.
Jorge ChahlaDepartment of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, USA.
Luke V TollefsonTwin Cities Orthopedics, Edina, Minnesota, USA.
David A ParkerSydney Orthopaedic Research Institute, Sydney, New South Wales, Australia.
Filippo FamiliariDepartment of Orthopaedic and Trauma Surgery, Magna Graecia University, Catanzaro, Italy.ORCID http://orcid.org/0000-0002-3453-2043
Robert F LaPradeTwin Cities Orthopedics, Edina, Minnesota, USA.
Nicholas N DePhillipoDepartment of Orthopedics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Meniscus International Network (MenIN) Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate practices and preferences among expert sports knee surgeons regarding biologic augmentation techniques in meniscal repair.

methodsA 12-question multiple-choice survey was distributed to the Meniscus International Network (MenIN) Study Group. It covered biologic augmentation techniques for various meniscal tear types, both in isolation and with anterior cruciate ligament reconstruction (ACLR). Eight options were assessed: no augmentation, trephination, rasping, marrow venting, fibrin clot, platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC) and meniscal wrapping. Surgeons could select multiple techniques per scenario.

resultsForty-two surgeons participated: 42% from Europe, 18% from North America, 10% from Latin America, 21% from Asia and 9% from Africa/Oceania. For isolated meniscal tears (excluding meniscal root tears), 90% of surgeons used at least one biologic augmentation technique. For meniscal tears associated with ACLR, 66% of surgeons used at least one biologic augmentation technique. The most utilized techniques were rasping (19%-69%), trephination (7%-43%), and marrow venting (0%-74%). PRP (2%-19%), BMAC (0%-14%) and meniscal wrapping (0%-10%) were least used. Biologic augmentation was most frequent for isolated radial (93%), isolated bucket-handle (86%), isolated vertical (86%) and isolated horizontal tears (98% for younger patients, 86% for degenerative tears). ACLR-associated repairs had lower augmentation rates, and meniscal root tears showed the highest percentage of non-augmented repairs. Over 50% of surgeons use a single augmentation technique, while 20% use two techniques depending on tear type. Overall, 33.3% (n = 14) of surgeons reported utilizing PRP and/or BMAC for meniscal repair augmentation, with the highest use observed in South America (12%) based on geographic usage.

conclusionsThis survey provides insights into current meniscal repair practices among expert orthopaedic sports medicine surgeons. The findings reveal variability in approaches based on tear patterns and associated procedures, with a general preference for simpler mechanical augmentation techniques over more advanced biologics. For isolated meniscal tears (excluding meniscal root tears), 90% of surgeons in this cohort report using one or more biological augmentation techniques. LEVEL OF EVIDENCE: Level V, expert opinion.

Indexed as

Practice Patterns, Physicians'Tibial Meniscus InjuriesAnterior Cruciate Ligament ReconstructionHumansPlatelet-Rich PlasmaSurveys and Questionnairesbiologic augmentationmeniscusMeniscus International Network (MenIN) Study Srouprepair

Identifiers

PMID40331602
PMCPMC12850556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.